Atlas Trials

Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer

Clinical trial NCT00380029 · COMPLETED

Trial details

NCT number
NCT00380029
Sponsor
UNC Lineberger Comprehensive Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2006-05-01
Primary completion
2010-08-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.